serw-MX  [xml]  
 


    
 DeCS Categories

C05 Musculoskeletal Diseases .
C05.651 Muscular Diseases .
C05.651.662 Myotonic Disorders .
C10 Nervous System Diseases .
C10.668 Neuromuscular Diseases .
C10.668.491 Muscular Diseases .
C10.668.491.606 Myotonic Disorders .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.202 Carbohydrate Metabolism, Inborn Errors .
C16.320.565.202.449 Glycogen Storage Disease .
C16.320.565.202.449.448 Glycogen Storage Disease Type I .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.202 Carbohydrate Metabolism, Inborn Errors .
C18.452.648.202.449 Glycogen Storage Disease .
C18.452.648.202.449.448 Glycogen Storage Disease Type I .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.288 Disease .
D02 Organic Chemicals .
D02.065 Amides .
D02.065.199 Anilides .
D02.065.199.420 Flutamide .
D02.065.277 Benzamides .
D02.065.277.067 Bezafibrate .
D02.092 Amines .
D02.092.146 Aniline Compounds .
D02.092.146.113 Anilides .
D02.092.146.113.420 Flutamide .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.114 Butyrates .
D02.241.081.114.968 Isobutyrates .
D02.241.081.114.968.500 Fibric Acids .
D02.241.081.114.968.500.249 Bezafibrate .
D02.241.223 Acids, Carbocyclic .
D02.241.223.100 Benzoates .
D02.241.223.100.100 Benzamides .
D02.241.223.100.100.120 Bezafibrate .
D02.241.223.100.200 Chlorobenzoates .
D02.241.223.100.200.249 Bezafibrate .
D02.355 Ethers .
D02.355.726 Phenyl Ethers .
D02.355.726.305 Fibric Acids .
D02.355.726.305.249 Bezafibrate .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.127 Benzoates .
D02.455.426.559.389.127.085 Benzamides .
D02.455.426.559.389.127.085.101 Bezafibrate .
D02.455.426.559.389.127.250 Chlorobenzoates .
D02.455.426.559.389.127.250.249 Bezafibrate .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.654 Phenyl Ethers .
D02.455.426.559.389.657.654.305 Fibric Acids .
D02.455.426.559.389.657.654.305.249 Bezafibrate .
HP1 Homeopathy .
HP1.007 Homeopathic Philosophy .
HP1.007.262 Patients .
HP1.007.262.808 Disease .
HP2 Homeopathic Clinics .
HP2.029 Disease .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.002 Health-Disease Process .
SP5.001.002.013 Disease .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Myotonic Disorders .
Eulenburg Disease .
Eulenburg's Disease .
Paralysis Periodica Paramyotonia .
Paramyotonia Congenita Without Cold Paralysis .
Paramyotonia Congenita of von Eulenberg .
Von Eulenberg's Disease .
Disorder, Myotonic .
Disorders, Myotonic .
Myopathy, Myotonic .
Myotonic Disorder .
Myotonic Myopathies .
Myotonic Myopathy .
Von Eulenberg Disease .
Myopathies, Myotonic .
Myotonia Fluctuans .
Paramyotonia Congenita .
Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition. .
1.00
2242
 
Flutamide .
Apimid .
Apo-Flutamide .
Chimax .
Cytamid .
Drogenil .
Euflex .
Eulexin .
Eulexine .
Fluken .
Flulem .
Flumid .
Fluta 1A Pharma .
Fluta-GRY .
Fluta-cell .
Flutamin .
Flutandrona .
Flutaplex .
Flutexin .
Fugerel .
Grisetin .
Niftolide .
Novo-Flutamide .
Oncosal .
PMS-Flutamide .
Prostacur .
Prostica .
Prostogenat .
SCH-13521 .
Testotard .
Apo Flutamide .
ApoFlutamide .
Fluta GRY .
Fluta cell .
FlutaGRY .
Flutacell .
Novo Flutamide .
NovoFlutamide .
PMS Flutamide .
SCH 13521 .
SCH13521 .
Niftolid .
SCH-13521 .
An antiandrogen with about the same potency as cyproterone in rodent and canine species. .
0.47
 
Bezafibrate .
Azufibrat .
BM-15.075 .
Befibrat .
Beza-Lande .
Beza-Puren .
Bezabeta .
Bezacur .
Bezafibrat PB .
Bezafisal .
Bezalip .
Bezamerck .
Béfizal .
Cedur .
Difaterol .
Eulitop .
Lipox .
Reducterol .
Regadrin B .
Sklerofibrat .
Solibay .
durabezur .
BM 15.075 .
BM15.075 .
Beza Lande .
Beza Puren .
An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS. .
0.43
251134
 
Disease .
Diseases .
Illness .
Disease Concept Evolution .
A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. .
0.43
98817203
 
Glycogen Storage Disease Type I .
Deficiency, Glucosephosphatase .
Gierke Disease .
Gierke's Disease .
Glycogen Storage Disease 1 (GSD I) .
von Gierke's Disease .
Deficiencies, Glucose-6-Phosphatase .
Deficiencies, Glucosephosphatase .
Deficiency, Glucose-6-Phosphatase .
Disease, Gierke .
Disease, Gierke's .
Disease, von Gierke .
Disease, von Gierke's .
Gierkes Disease .
Glucose 6 Phosphatase Deficiency .
Glucose-6-Phosphatase Deficiencies .
Glucosephosphatase Deficiencies .
von Gierkes Disease .
Glucosephosphatase Deficiency .
Glucose-6-Phosphatase Deficiency .
Glycogenosis 1 .
Hepatorenal Glycogen Storage Disease .
von Gierke Disease .
Von Gierke's Disease .
An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood. .
0.43
231247